Paula Soteropoulos
Lead Independent DirectorMs. Paula Soteropoulos is Venture Advisor of 5AM Venture Management, LLC from 2026. She joined the 5AM Venture Management, LLC in 2020. She was Venture Partner of 5AM Venture Management, LLC from 2022 to 2026. She was Strategic Advisor of 5AM Venture Management, LLC from March 2020 to 2022. She serves as Independent Director at Dianthus Therapeutics, Inc since September 2023. She served as Executive Chairman of the Board at Ensoma, Inc. until October 2021 and serves as its Chairman of the Board since October 2021 and served as its Interim CEO since January 2024 until 2024. She serves as Director of Rallybio LLC since November 2020. Ms. Soteropoulos has been Independent Director at Rallybio Corporation since October 2020 and serves as its Lead Independent Director since December 2023. From January 2015 to September 2019, she served as President and Chief Executive Officer of Akcea Therapeutics, Inc. She serves as Advisor at Akcea Therapeutics, Inc. since September 23, 2019. She had been a Director of uniQure N.V. since July 22, 2013 until June 18, 2024. She served as a Member of Supervisory Board at uniQure N.V. since July 22, 2013 until June 15, 2016. Prior to joining Akcea, Ms. Soteropoulos was a Member of the executive leadership team of Moderna Therapeutics as the Cardiometabolic Business Unit General Manager and Senior Vice President of Strategic Alliances from July 2013 to December 2014, a global strategic and operating management executive with success at building high-performance global teams, leading complex development programs from early stage through approval and commercializing global products. She has rare disease biopharma industry experience in strategic and operational leadership areas including drug development, global commercialization, manufacturing, new company formation and company building. Ms. Soteropoulos worked at Genzyme Corporation, a biotechnology company, from 1992 to 2013, most recently as Vice President and General Manager, Cardiovascular, Rare Diseases. Prior to Moderna, Ms. Soteropoulos served as the Vice President and General Manager of Genzyme’s Global Cardiovascular business. She was responsible for the development and commercialization of multiple therapeutics across Renal, Transplant & Oncology, Rare Disease and Cardiovascular. During her tenure at Genzyme, she was instrumental in advancing new compounds from discovery through clinical development and commercialization with significant roles driving product strategy, portfolio, program and alliance management, sales and marketing and business development. Additionally, Ms. Soteropoulos led strategic manufacturing capacity planning, supply chain development and manufacturing process development. Prior to Genzyme, she was a Bioprocess Engineering Consultant for various biopharmaceutical companies. She serves as Director at JFYNet. She serves as a Member of Advisory Board at the Tufts University Chemical and Biological Engineering Department. She is a Member of the Healthcare Business Women’s Association and serves as a Mentor. She was an honoree of Mass High Tech’s Women to Watch. She served as Director of Akcea Therapeutics, Inc. since January 2015 until September 18, 2019 and its President since January 2015 until April 17, 2018. Ms. Soteropoulos earned her B.S. and M.S. in Chemical and Biochemical Engineering from Tufts University and earned an Executive Management Certificate from Darden School of Business, University of Virginia.
Positions
- Company NameRallybio CorporationStock CodeRLYBPositionLead Independent Director
- Company NameDianthus Therapeutics, Inc.Stock CodeDNTHPositionIndependent DirectorColleagues
- MGMarino GarciaPresident, CEO & Director
- AFAlison F. LawtonIndependent Chairman of the Board
- RSRyan SavitzExecutive VP, CFO, Chief Business Officer & Treasurer
- SRSimrat RandhawaExecutive VP and Head of R&D
- EGEdward G. CarrSenior VP & Chief Accounting Officer
- JTJudson TaylorSenior VP & Head of Technical Operations
- PSPaula SoteropoulosIndependent Director
- AMAnne M. McGeorgeIndependent Director
- JVJonathan ViolinIndependent Director
